Z-1020-2022Class II
Atellica IM Enhanced Estradiol (eE2) 100T - In vitro diagnostic use in the quantitative determination of...
Siemens Healthcare Diagnostics Inc. / initiated 2022-03-03 / Open, Classified
Siemens Healthcare Diagnostics, Inc. began a recall of Atellica IM Enhanced Estradiol (eE2) 100T - In vitro diagnostic use in the quantitative determination of estradiol SMN: 10995561 All lots on . FDA classified it as Class II and gives the reason as "Falsely Elevated Results Observed with Plasma Specimens, could lead a clinician to misinterpret patient results". As of , the recall status on record is Open, Classified.
Recall record
- Recall number
- Z-1020-2022
- Classification
- Class II
- Status
- Open, Classified
- Initiated
- Posted
- Recalling firm
- Siemens Healthcare Diagnostics Inc.
- Product
- Atellica IM Enhanced Estradiol (eE2) 100T - In vitro diagnostic use in the quantitative determination of estradiol SMN: 10995561 All lots
- Product code
- CHP Radioimmunoassay, Estradiol
- Reason for recall
- Falsely Elevated Results Observed with Plasma Specimens, could lead a clinician to misinterpret patient results
- FDA root cause
- Under Investigation by firm
- Action
- Siemens issued an Urgent Medical Device Correction AIMC 22-03.A.US and Urgent Field Safety Notice AIMC 22-03.A.OUS on 3/3/22. Letter states reason, health risk and action to take: Customers must discontinue use of plasma specimens for testing with the Atellica IM and ADVIA Centaur eE2 assays until further notice. Customers may continue to use the Atellica IM eE2 and ADVIA Centaur eE2 assays with serum specimens. Please review this letter with your Medical Director. Complete and return the Field Correction Effectiveness Check Form attached to this letter within 30 days. If you have received any complaints of illness or adverse events associated with the products listed in Table 1, immediately contact your local Siemens Healthineers Customer Care Center or your local Siemens Healthineers technical support representative. Please retain this letter with your laboratory records and forward this letter to those who may have received this product. Questions: contact your Siemens Healthineers Customer Care Center or your local Siemens Healthineers technical support representative
- Quantity in commerce
- 2,044 units
- Distribution
- Worldwide distribution - US Nationwide and the countries of Austria, Belgium, Brazil, Bulgaria, Burkina, Faso Country AG, Cyprus, Denmark, Egypt, Estonia, Finland, France, French Polynesia, Georgia, Greece, Guadeloupe, India, Ireland, Israel, Italy, Kazakhstan, Latvia, Lithuania, Macedonia, Malta, Morocco, Nepal, Netherlands, Norway, Palestinian Ter, Paraguay, Poland, Portugal, Qatar, Romania, Russian Fed., Slovakia, Spain, Sweden, Switzerland, Turkey, Turkmenistan, U.A.E., Ukraine, United Kingdom, Vatican city.
- Product codes and lots
- All lot numbers UDI: (01)00630414598857(10)53376082(17)20220521 (01)00630414598857(10)53377082(17)20220521 (01)00630414598857(10)70533084(17)20220804
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-1020-2022 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-1021-2022 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-1022-2022 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-1023-2022 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-1024-2022 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-1025-2022 | Class II | Ongoing | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
